Meningococcal Disease Completed Phase 3 Trials for Penciclovir (DB00299)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01000311A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 MonthsPrevention